Dr. Aaron Fenster is making the use of radiation seeds in breast cancer treatments more efficient and accurate.
The LaparoGuard system integrates hardware and software to provide imageless, soft tissue surgical navigation that will help reduce and prevent instrument-on-tissue collisions that cause injury during laparoscopic surgery.
Pioneering technology allows life-changing skull defect reconstructions of any size, shape or complexity using custom molds to create patient-specific titanium craniomaxillofacial surgical implants.
Longitudinal 3D visualizations for mapping, measuring, and analyzing nerves to pinpoint disruptions such as entrapments, impingements, tumours, and dislocations before any treatment is considered or undertaken.
Millions of women worldwide will potentially gain access to early breast cancer detection through the use of more cost-effective, X-ray Light Valve (XLV) technology integrated within a custom-made, economic, digital mammography machine.
Delivering a novel therapeutic molecule across the blood-brain barrier to prevent amyloid beta from aggregating into harmful plaques.
Dramatically improving the standard of prostate cancer diagnosis and treatment by enabling urologists to co-register MRI prostate images with live ultrasound to accurately target suspicious cancer regions during transrectal ultrasound (TRUS) biopsy and prostate cancer therapy procedures.
A novel imaging technology that uses electromagnetic and acoustic waves to enhance ultrasound images that significantly improve identification of suspicious tissue and tumours in any number of applications – liver and prostate are the focus of the first products to market.
The potential to profoundly impact liver cancer treatment in developing countries such as India, North Asia and part of Europe where access to CT and MR scanners is extremely limited.